News

This has been an exciting year for medical office technology. Improvements in otoscopy, hemoglobin analyzers, tissue adhesives, and topical skin preps top the list of innovations.

Most adolescents who commit suicide saw a physician in the weeks or months before death. You can play a key role in preventing such tragedy by recognizing predisposing signs and symptoms and collaborating with mental health professionals to help vulnerable patients.

Every year, no matter how many times I consult the dosing chart for inactivated influenza vaccine, I still find myself forgetting when to give 0.25 mL (cc) vs. 0.5 mL (cc) and when to give two doses.

Eye on Washington

Safer drugs, childhood obesity, and a plan to deliver flu vaccine this season

Frank A. Oski, Walter W. Tunnessen, and Catherine Caldwell Brown are remembered by a colleague for their inestimable contribution to this publication.

Pediatricians have an obligation to aid children and adolescents who are exposed to family alcohol or other drug abuse or dependence. Asking the right questions, showing empathy, and guiding patients and families to available resources are the keys to motivating change.

Eye on Washington

This has been a contentious and generally unproductive session of Congress, with little major legislation passed, authorization bills still incomplete, and much attention paid to pushing potentially awkward votes on such issues as keeping the phrase "under God" in the Pledge of Allegiance and reinstating the military draft. Some $145 billion worth of tax cuts sought by President George W. Bush were enacted—without alternative sources of revenue identified. Legislation that would legalize reimportation of prescription drugs from Canada failed to get a hearing.

Once more, the United States doesn't have enough of a vaccine—this time, flu vaccine. Just as the influenza season was about to start, the bad news hit the headlines: The entire output of the California-based Chiron company's influenza vaccine has been condemned by the authorities in the United Kingdom, where Chiron's vaccine, Fluvinir, is manufactured. US authorities had counted on 100 million doses of flu vaccine this year—up from 87 million available last year. About half that amount was to be supplied by Chiron.

Collecting stool specimens from an infant who has diarrhea is difficult, especially if the stool is watery and soaks into the diaper before it can be collected.

Your young patients are more likely to survive to very old age than did previous generations. Will they flourish as senior citizens or be limited by illness and disability? In large measure, that depends on whether their families put into practice the advice you give—advice that comes out of an expanding body of remarkable, illuminating research.

It's time for the closely watched Medical Economics magazine annual survey of physicians' earnings, and—in the latest findings, from 2003—you and your colleagues are once again (almost) at the bottom of the pile.

On October 5, 2004, the United States learned that only half the anticipated doses of influenza vaccine would be available in preparation for the upcoming flu season because Chiron Vaccines, one of only two manufacturers of inactivated influenza vaccine, had its license to manufacture Fluvirin suspended. This may be the most abrupt and untimely interruption of the vaccine supply we have experienced but, as health-care providers for children well know, it isn't the first.

Once more, the United States doesn't have enough of a vaccine—this time, flu vaccine. Just as the influenza season was about to start, the bad news hit the headlines: The entire output of the California-based Chiron company's influenza vaccine has been condemned by the authorities in the United Kingdom, where Chiron's vaccine, Fluvinir, is manufactured. US authorities had counted on 100 million doses of flu vaccine this year—up from 87 million available last year. About half that amount was to be supplied by Chiron.

The medical office of the future is here, and it's electronic. Personal digital assistants (PDAs), tablets, and wireless applications are already making significant inroads into daily practice for many pediatricians. Within a few years, every clinician will probably be using them.

Children who don't talk about high-profile disasters such as the September 11, 2001, terrorist attacks or, before that, the shootings at Columbine High School aren't coping &#8212 they're avoiding. Pediatricians can help them come to terms with their fears.